Results 1 to 10 of about 342,683 (247)

Impact of seasonal malaria chemoprevention: a plausibility evaluation of routine data from health facilities in three implementing states in Nigeria [PDF]

Malaria Journal
Background Seasonal malaria chemoprevention (SMC) has been recommended by the World Health Organization since 2012 for eligible children in areas where malaria transmission is highly seasonal and intense. By 2024, SMC had been successfully implemented in
Ebenezer C. Ikechukwu, Ekechi Okereke, Olabisi Ogunmola, Jennifer Chukwumerije, Daniel Emeto, Emmanuel Salifu, Ayodeji Balogun, Chibuzo Oguoma, Emmanuel Shekarau, Nnenna Ogbulafor, Eoin Cassidy, Christian Rassi, Olusola Oresanya, Chukwudi A. Nnaji   +13 more
doaj   +2 more sources

Eliminating Plasmodium falciparum malaria: results from tailoring active case detection approaches to remote populations in forested border areas in north-eastern Cambodia

Malaria Journal, 2021
Background Remaining Plasmodium falciparum cases in Cambodia are concentrated in forested border areas and in remote populations who are hard to reach through passive case detection.
Ann-Sophie Stratil, Lieven Vernaeve, Sergio Lopes, Yves Bourny, Kylie Mannion, Prudence Hamade, Arantxa Roca-Feltrer, James K. Tibenderana, Siv Sovannaroth, Mark Debackere   +9 more
doaj   +1 more source

A non-randomized controlled trial to assess the protective effect of SMC in the context of high parasite resistance in Uganda

Malaria Journal, 2023
Background Until recently, due to widespread prevalence of molecular markers associated with sulfadoxine-pyrimethamine (SP) and amodiaquine (AQ) resistance in east and southern Africa, seasonal malaria chemoprevention (SMC) has not been used at scale in ...
Anthony Nuwa, Kevin Baker, Craig Bonnington, Musa Odongo, Tonny Kyagulanyi, John Baptist Bwanika, Sol Richardson, Jane Nabakooza, Jane Achan, Richard Kajubi, David Salandini Odong, Maureen Nakirunda, Godfrey Magumba, Geofrey Beinomugisha, Madeleine Marasciulo-Rice, Hilda Abio, Christian Rassi, Damian Rutazaana, Denis Rubahika, James Tibenderana, Jimmy Opigo   +20 more
doaj   +1 more source

Spontaneous adverse drug reaction reporting during the seasonal malaria chemoprevention campaign in 2022

Bulletin of the National Research Centre, 2023
Background Seasonal administration of antimalaria drug, sulphadoxine/pyrimethamine plus amodiaquine to children 3–59 months is a malaria preventive intervention used for the reduction of childhood malaria morbidity and mortality in area with highly ...
Kunle Rotimi, Babatunde Fagbemi, Taiwo Ibinaiye, Jimmy Aiden, Victor Gabriel, Chrysantus Dabes, Tapshak Kyeshir, Daniel Oguche, Omolola Obayemi, Aminu Biambo, Andrew Okwulu, Adaeze Aidenagbon   +11 more
doaj   +1 more source

Optimizing the role of ‘lead mothers’ in seasonal malaria chemoprevention (SMC) campaigns: formative research in Kano State, northern Nigeria

Malaria Journal, 2023
Background Seasonal malaria chemoprevention (SMC) is a safe and effective intervention for preventing malaria in children under 5 years of age. Lead mothers are community health volunteers that help caregivers comply with monthly administration of anti ...
Ekechi Okereke, Helen Smith, Chibuzo Oguoma, Olusola Oresanya, Kolawole Maxwell, Chinedu Anikwe, Lawrence Chijioke Osuji, Obianuju Ogazi, Jamila Musa, Ashiru Rajab, Emmanuel Shekarau, Festus Okoh, Erica Viganò, Laura Donovan, Charlotte Ward, Kevin Baker   +15 more
doaj   +1 more source

Predictors of caregiver adherence to administration of amodiaquine during delivery of seasonal malaria chemoprevention in Nigeria, Burkina Faso, Chad, and Togo

Malaria Journal, 2023
Background Malaria is the leading cause of morbidity and mortality among infants and children under-five in sub-Saharan Africa. In the Sahel, seasonal malaria chemoprevention (SMC) is delivered door-to-door in monthly cycles.
Taiwo Ibinaiye, Olusola Oresanya, Chibuzo Oguoma, Adaeze Aidenagbon, Olabisi Ogunmola, Christian Rassi, Sol Richardson   +6 more
doaj   +1 more source

Insights into malaria susceptibility using genome-wide data on 17,000 individuals from Africa, Asia and Oceania

Nature Communications, 2019
Four genome-wide associated loci are currently known for malaria susceptibility. Here, the authors expand on earlier work by combining data from 11 malaria-endemic countries and additional population sequencing informing an African-enriched imputation ...
Malaria Genomic Epidemiology Network
doaj   +1 more source

Correction to: Monitoring changes in malaria epidemiology and effectiveness of interventions in Ethiopia and Uganda: Beyond Garki Project baseline survey

Malaria Journal, 2019
Please be advised that one of the author names is incorrectly spelled in the published article: ‘Irene Kyomuhagi’ should be ‘Irene Kyomuhangi’.
Tarekegn A. Abeku, Michelle E. H. Helinski, Matthew J. Kirby, Takele Kefyalew, Tessema Awano, Esey Batisso, Gezahegn Tesfaye, James Ssekitooleko, Sarala Nicholas, Laura Erdmanis, Angela Nalwoga, Chris Bass, Stephen Cose, Ashenafi Assefa, Zelalem Kebede, Tedila Habte, Vincent Katamba, Anthony Nuwa, Stella Bakeera-Ssali, Sarah C. Akiror, Irene Kyomuhangi, Agonafer Tekalegne, Godfrey Magumba, Sylvia R. Meek   +23 more
doaj   +1 more source

Co-implementing vitamin A supplementation with seasonal malaria chemoprevention in Sokoto State, Nigeria: a feasibility and acceptability study

BMC Health Services Research, 2022
Background Bi-annual high dose vitamin A supplements administered to children aged 6–59 months can significantly reduce child mortality, but vitamin A supplementation (VAS) coverage is low in Nigeria.
Olusola Oresanya, Abimbola Phillips, Ekechi Okereke, Abraham Ahmadu, Taiwo Ibinaiye, Madeleine Marasciulo, Charlotte Ward, Olatunde Adesoro, Rilwanu Mohammed, Jamilu Nikau, Chris Osa Isokpunwu, Mohammad Ali Inname, Helen Counihan, Kevin Baker, Kolawole Maxwell, Helen Smith   +15 more
doaj   +1 more source

Health systems readiness and quality of inpatient malaria case-management in Kano State, Nigeria

Malaria Journal, 2020
Background Nigeria was among the first African countries to adopt and implement change of treatment policy for severe malaria from quinine to artesunate.
Abiodun A. Ojo, Kolawole Maxwell, Olusola Oresanya, Justice Adaji, Prudence Hamade, James K. Tibenderana, Saddiq S. Abubakar, Bala M. Audu, Ahmad Njidda, Aishatu B. Gubio, Robert W. Snow, Dejan Zurovac   +11 more
doaj   +1 more source